Nurse Practitioner, Family · Sebring, FL
NPI
1558509612
Since 2009
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
111 Medical Center Ave
Sebring, FL, 33870
Phone (863) 403-4023
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
925 services
Medicare patients, 2024
341
Average age 74
Drug cost, 2024
$3.2M
6,150 prescriptions
Company payments, 2025
$1,681
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hannah Campbell was code 99214 (office e&m - established), 701 times for 326 patients. In total Hannah Campbell billed 925 services in 10 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 701 | 326 | $71.15 | $50K |
| 95251 Test - Miscellaneous | Office | 148 | 74 | $20.74 | $3,070 |
| 99204 Office E&M - New | Office | 41 | 41 | $97.57 | $4,000 |
| 99213 Office E&M - Established | Office | 25 | 18 | $42.81 | $1,070 |
By year: 2022 $32K for 426 services; 2023 $86K for 1,133 services; 2024 $59K for 925 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hannah Campbell prescribed most often to Medicare patients was Levothyroxine Sodium, with 619 prescriptions and refills. In total Hannah Campbell wrote 6,150 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 619 | 1,766 | 186 | $5,430 |
| Mounjaro Tirzepatide | 450 | 540 | 86 | $576K |
| Ozempic Semaglutide | 442 | 669 | 94 | $624K |
| Synthroid Levothyroxine Sodium | 291 | 674 | 71 | $27K |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 287 | 496 | 73 | $301K |
| Trulicity Dulaglutide | 231 | 294 | 48 | $279K |
| Liothyronine Sodium Generic | 214 | 521 | 60 | $7,254 |
| Metformin Hcl Generic | 207 | 589 | 65 | $1,093 |
| Tresiba Flextouch U-200 Insulin Degludec | 170 | 399 | 50 | $182K |
| Metformin Hcl Er Metformin Hcl | 168 | 426 | 49 | $1,155 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 159 | 384 | 55 | $16K |
| Glimepiride Generic | 153 | 429 | 48 | $1,168 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 134 | 254 | 29 | $146K |
| Glipizide Generic | 121 | 359 | 42 | $817 |
| Tresiba Flextouch U-100 Insulin Degludec | 112 | 202 | 40 | $75K |
Brand drugs: 3,703 claims; generic drugs: 2,056 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hannah Campbell $1,681 ($1,681 in general payments such as food, travel and fees) from 19 companies. The largest payer was Corcept Therapeutics with $345.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 11 | $345 |
| Amgen Inc. AMGN | 15 | $296 |
| Xeris Pharmaceuticals, Inc. | 10 | $220 |
| Novo Nordisk Inc NVO | 6 | $114 |
| Dexcom, Inc. DXCM | 4 | $90.22 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $82.86 |
| Ascendis Pharma Endocrinology Inc ASND | 3 | $79.97 |
| IBSA Pharma Inc. | 4 | $73.65 |
| Lilly USA, LLC LLY | 3 | $56.89 |
| Calliditas Therapeutics US Inc. | 2 | $50.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.